Independent regional clinical laboratory expects net income in the third quarter to be even with the prior year third quarter and hopes to see an improvement in fourth-quarter results over the prior ...

Although we don't believe intiming the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. What: Shares ...

The Web cast will be archived, on both Web sites, for 30 days following the call. About Bio-Reference Laboratories, Inc. The Company is the largest independent regional clinical laboratory in the ...

NJBIZ, New Jersey’s leading business journal, provides 24/7 business news coverage and events honoring top business professionals.

What: Marc D. Grodman, M.D., President and CEO of Bio-Reference Laboratories, Inc. (BRLI) will preside over the closing bell to celebrate the Company's 20th listing anniversary on NASDAQ. Where: ...

Bio-Reference Laboratories (BRLI), which provides lab testing services, earlier today reported Q3 EPS of 45c, compared with analysts' consensus estimate of 43c. The company's revenue was $172.3M, ...

Bio-Reference Laboratories is up 81 cents, or 14.6 percent, to $6.37, after the Elmwood Park, N.J., firm reaffirmed its outlook for at least a 100 percent increase in pre-tax net income and a 20 ...

ELMWOOD PARK, N.J.--(BUSINESS WIRE)-- CEO Marc Grodman M.D. of Bio-Reference Laboratories, Inc. (BRLI) (NASDAQ – BRLI) was one of the key panelists at a November 17 bi-partisan policy forum in ...

Bio-Reference Laboratories (NASDAQ: BRLI) reported earnings on June 6. Here are the numbers you need to know. The 10-second takeaway For the quarter ended April 30 (Q2), Bio-Reference Laboratories met ...

Q3 EPS $0.46 vs est. EPS $0.38 Q3 rev $97.4 mln vs est. $91.3 mln Number of patients served up 20 pct in Q3 Shares hit lifetime high Sept 2 (Reuters) - Bio-Reference Laboratories Inc reported a better ...